KEBOMED A/S: Financial statements 2019
CVR: 28490704
Source: annual report 2019, Danish Business Authority
01/07/2018 – 30/06/2019
KEBOMED A/S (CVR 28490704) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 37,753,396 and a net result of DKK 8,254,157 compared with DKK 11,571,385 the year before. That is a decrease of 8.4% compared with the year before. Equity in the 2019 report amounted to DKK 9,315,548. The solvency ratio was 19.6%.
- Gross Profit
- DKK 37,753,396
- Profit/Loss
- DKK 8,254,157
- Equity
- DKK 9,315,548
- Total Assets
- DKK 47,597,894
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 37.8M | 8.3M | 9.3M | - |
| 2018 | - | 41.2M | 11.6M | 12.6M | - |
| 2017 | - | 40.9M | 6.8M | 16.8M | - |
| 2016 | - | 37.7M | 9M | 10M | - |
| 2015 | - | 38.9M | 9.8M | 6.9M | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout KEBOMED A/S
KEBOMED A/S is a Danish company of the type Aktieselskab based in Glostrup, founded in 2005. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named KEBO MED A/S. The management consists of Henrik Schjødt. The board consists of Niels Søren Frederik Kornerup (chair), Henrik Schjødt and Søren Dalmark Kornerup. The company is owned by Kebomed Europe Holding AG. The company has 23 employees (2026). In 2026, the company reported a gross profit of DKK 52,977,983 and a net result of DKK 13,110,236 compared with DKK 9,827,524 the year before. Equity in the 2026 report amounted to DKK 36,352,192.